AHead Simulations was founded solely for incorporating simulation educational technology within hearing healthcare to better education, training, and the client experience. AHead’s main product, CARL is the only patient simulator platform to combine a physical patient simulator with clinical resources and curriculum to maximize clinical success.
News
neuroLytixs
on January 27, 2022Neurolytixs’ ground-breaking technologies leverages artificial intelligence to diagnose concussions with blood biomarkers within 48 hours of an incident. Their research has identified a number of blood biomarkers that accurately identify brain injury among patients. This technology is the first test of its kind to yield accuracy in concussion diagnosis.
Front Line Medical
on January 27, 2022Front Line Medical is a medical device company lowering the barriers to bleeding control and resuscitation worldwide. The company offers a life-saving tool, the COBRA-OS™ to help patients in emergency situations. Used for REBOA procedures, the COBRA-OS’ smaller size decreases both the time it takes to complete the procedure and risk of complications.
Read moreKGK Synergize
on October 20, 2021KGK Science provides high-quality clinical research trials and expert regulatory support for the nutraceutical, cannabis and hemp industries. For over 22 years, we have successfully helped hundreds of companies with custom designed clinical trials and claim substantiation strategies to move products efficiently into global markets.
LifeLike BioTissue
on October 20, 2021Founded in London, Ontario, Canada, LifeLike BioTissue has been providing realistic surgical simulators to facilitate and increase the quality and ease of surgical skills training for over a decade.
Read morePrecision Proteomics
on October 20, 2021Precision Proteomics is a pre-clinical stage biotechnology company commercializing a novel platform for the development of next-generation precision medicines. Precision’s technology can systematically and quantitatively profile activations of key signal pathways that drive pathogenesis and the development of resistance to therapy.
Read more
Aufero Medical Technologies
on October 20, 2021Aufero Medical Technologies have developed a device for the treatment of cardiac arrhythmia. The device will maintain contact force at a specified level during the procedure, reducing arrhythmia recurrence and repeat surgery.
Read moreCellAdore Skin Health Inc.
on October 20, 2021CellAdore Skin Health Inc.’s mission is to develop, manufacture and distribute premium products to consumers to enhance and maintain their skin health. Their vision is to be the trusted brand for skin health products developed based on rigorous scientific evidence.
Read more